| Medical and Health Sciences | 2021-2025 | 89 | SE 3 | 99.98 |
| Cardiology and Cardiovascular Medicine | Lifetime | 145 | SE 4 | 99.83 |
| Surgery | Lifetime | 897 | SE 17 | 99.16 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 10 | SE 1 | 99.96 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 191 | SE 5 | 96.56 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 357 | SE 3 | 96.55 |
| Cardiovascular Function and Risk Factors | Lifetime | 79 | SE 2 | 99.82 |
| Mechanical Circulatory Support Devices | Lifetime | 40 | SE 1 | 99.65 |
| Transplantation: Methods and Outcomes | Lifetime | 45 | SE 1 | 99.51 |
| Heart Failure Treatment and Management | Lifetime | 57 | SE 3 | 99.76 |
| Cardiac pacing and defibrillation studies | Lifetime | 89 | SE 4 | 99.65 |
| Cardiac Structural Anomalies and Repair | Lifetime | 135 | SE 1 | 99.52 |
| Potassium and Related Disorders | Lifetime | 33 | SE 3 | 99.28 |
| Diabetes Treatment and Management | Lifetime | 556 | SE 15 | 98.01 |
| Heart rate and cardiovascular health | Lifetime | 110 | SE 3 | 92.49 |
| Medication Adherence and Compliance | Lifetime | 784 | SE 26 | 91.35 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 6 | SE 1 | 99.85 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 11 | SE 1 | 99.93 |
| Heart Failure Treatment and Management | 2021-2025 | 11 | SE 1 | 99.90 |
| Potassium and Related Disorders | 2021-2025 | 9 | SE 2 | 99.31 |
| Diabetes Treatment and Management | 2021-2025 | 151 | SE 5 | 98.34 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 216 | SE 1 | 97.12 |
| Mechanical Circulatory Support Devices | 2021-2025 | 320 | SE 2 | 95.85 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 779 | SE 9 | 95.26 |
| Cardiac electrophysiology and arrhythmias | 2021-2025 | 448 | SE 4 | 94.27 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 644 | SE 12 | 91.29 |
| Medication Adherence and Compliance | 2021-2025 | 195 | SE 5 | 88.51 |
| Electrolyte and hormonal disorders | 2021-2025 | 168 | SE 6 | 86.32 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 861 | SE 16 | 82.62 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 951 | SE 21 | 78.91 |
| Hormonal Regulation and Hypertension | 2021-2025 | 922 | SE 22 | 79.48 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 262 | SE 2 | 77.84 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 361 | SE 2 | 56.86 |
